Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 2000
Summary
- Conditions
- Chemotherapy-induced Febrile Neutropenia (FN)
- Malignant Hemopathy
- Solid Tumors
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01574235
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon